Customers: UNITED STATES AIR FORCE (USAF) Contractors: ElectroCore Project date: 2021/06
|
In mid-June, the US Air Force began using a low-voltage electric device to stimulate the vagus nerve gammaCore from ElectroCore to maintain the vigor of soldiers who were not sleeping for 34 hours.
GammaCore is a portable non-invasive device that stimulates the vagus nerve by producing weak 120-second electrostimulation cycles that focus on relieving and eliminating migraine symptoms. GammaCore Sapphire has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of headaches, including migraines.
The study, which examines whether GammaCore can improve vigilance by modulating activity in an area brain called the blue spot, which plays a major role in regulating attention and wakefulness, involved 40 U.S. Air Force personnel. The researchers found that the vagus nerve has substantial associations with the blue spot, so the hypothesis was that this device could GammaCore improve cognitive functions in sleep-deprived people.
Participants in the experiment who did not sleep 34 hours were divided into two groups - the first received fictitious stimulation, the second was directly exposed to the GammaCore device. At the 12-hour mark of the study, participants from the active exposure group GammaCore used the device for 6 minutes. The results showed that subjects who received real stimulation felt less fatigue and did better with tests for concentration and multitasking (5% productivity drop in 24 hours) compared to those who received fictitious stimulation (15% performance drop in 24 hours).
Scientists will need much more time to argue that this kind of impact can be applied to people in real conditions, in particular, it is necessary to find out exactly how to "dose" this type of electrical stimulation.[1]